FHTX R&D Expense Growth
Foghorn Therapeutics Inc · R&D Expense Growth
FHTX R&D Expense Growth
Latest reported-9.59%period ending
FHTX FY R&D Growth (YoY) (0.00% → -9.59%)
Latest values, visible window
High-resolution chart · PNG
FHTX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -9.5866% | |
| -13.8218% | |
| 3.8545% | |
| 31.4883% | |
| 39.1753% | |
| 30.1001% | |
| 109.0082% | |
| 0% |